CYG
PACB icon

Clean Yield Group’s Pacific Biosciences PACB Stock Holding History

Clean Yield Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,500
Closed -$12K – 376
2020
Q2 		$12K Sell
3,500
-1,500
-30% -$5.11K 0.01% 295
2020
Q1 		$15K Sell
5,000
-8,000
-62% -$32.8K 0.01% 288
2019
Q4 		$67K Hold
13,000
– – 0.02% 203
2019
Q3 		$67K Buy
13,000
+8,000
+160% +$44.7K 0.02% 194
2019
Q2 		$30K Hold
5,000
– – 0.01% 236
2019
Q1 		$36K Hold
5,000
– – 0.01% 212
2018
Q4 		$37K Buy
+5,000
New +$31.7K 0.02% 202

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Clean Yield Group's PACB Position: Q3 2020 in Review

Clean Yield Group sold out of Pacific Biosciences (PACB) in Q3 2020, closing a stake of 3,500 shares — an estimated $12K sold.

Clean Yield Group first reported a position in PACB in Q4 2018 and held it in 7 quarters. The position peaked at $67K in Q4 2019. 174 funds tracked by Wall St. Rank hold PACB as of Q3 2020.

  • Clean Yield Group reported no remaining Pacific Biosciences position as of Q3 2020 after selling out during the quarter.
  • Clean Yield Group sold 3,500 Pacific Biosciences shares in Q3 2020, an estimated $12K.
  • Clean Yield Group first reported a position in Pacific Biosciences in Q4 2018 and held it in 7 quarters.
  • Clean Yield Group's Pacific Biosciences position peaked at $67K in Q4 2019.
  • 174 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2020.

Based on Clean Yield Group's 13F filing for Q3 2020, filed 16 Oct 2020.